BX Swiss TOP 30 CHF
1.384,70
PKT
+20,72
PKT
+1,52
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 26.09.24 | Richemont Sector Perform | RBC Capital Markets | |
| 24.09.24 | Richemont Buy | UBS AG | |
| 24.09.24 | Richemont Overweight | JP Morgan Chase & Co. | |
| 23.09.24 | Nestlé Sector Perform | RBC Capital Markets | |
| 20.09.24 | Richemont Buy | Jefferies & Company Inc. | |
| 20.09.24 | Givaudan Hold | Deutsche Bank AG | |
| 20.09.24 | Nestlé Neutral | UBS AG | |
| 20.09.24 | Richemont Buy | Goldman Sachs Group Inc. | |
| 19.09.24 | Zurich Insurance Overweight | Barclays Capital | |
| 19.09.24 | Zurich Insurance Overweight | Barclays Capital | |
| 19.09.24 | Swiss Re Equal Weight | Barclays Capital | |
| 19.09.24 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.09.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 18.09.24 | Givaudan Underperform | Jefferies & Company Inc. | |
| 18.09.24 | Givaudan Buy | Goldman Sachs Group Inc. | |
| 18.09.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 18.09.24 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
| 18.09.24 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 17.09.24 | Givaudan Neutral | UBS AG | |
| 17.09.24 | Givaudan Neutral | UBS AG | |
| 17.09.24 | Givaudan Underperform | Jefferies & Company Inc. | |
| 17.09.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 17.09.24 | Richemont Overweight | Barclays Capital | |
| 16.09.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 16.09.24 | Roche Neutral | UBS AG | |
| 13.09.24 | Swiss Re Sector Perform | RBC Capital Markets | |
| 13.09.24 | Givaudan Neutral | UBS AG | |
| 13.09.24 | Roche Sell | Deutsche Bank AG | |
| 12.09.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 11.09.24 | Novartis Buy | UBS AG | |
| 11.09.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 10.09.24 | Roche Neutral | UBS AG | |
| 10.09.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 10.09.24 | Richemont Outperform | Bernstein Research | |
| 10.09.24 | Roche Hold | Deutsche Bank AG | |
| 10.09.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 09.09.24 | Roche Neutral | UBS AG | |
| 09.09.24 | Givaudan Neutral | UBS AG | |
| 09.09.24 | UBS Overweight | JP Morgan Chase & Co. | |
| 09.09.24 | Richemont Overweight | Barclays Capital |